Editorial Policy

TriedRx exists because the peptide information landscape is dominated by two failure modes: vendors writing product pages that double as clinical guidance, and community forums recycling anonymous dosing advice without a source chain. We built TriedRx to sit in the middle — an independent editorial operation that writes about what the primary literature actually says, and an independent vendor-rating platform that aggregates publicly available quality, transparency, and reputation data into a consistent, transparent rubric. Think Consumer Reports for the peptide market: we compile the data, we grade the vendors, we publish the rankings — and we publish what's missing.

This page describes the rules that govern everything published on TriedRx: what we will publish, what we refuse to publish, how we source claims, how we correct mistakes, and how we stay financially independent from the vendors we cover.

What TriedRx Is — and Isn't

TriedRx is an independent peptide-vendor research and rating platform. We compile publicly available lab reports (certificates of analysis, HPLC and mass spectrometry data that vendors publish or that independent researchers have tested and published), transparency disclosures, reputation signals, regulatory actions, and operational data. We aggregate these inputs and grade vendors on a documented rubric. Our rankings are editorial opinions based on the data we can verify.

TriedRx is not a laboratory. We do not operate our own chromatography, mass spec, or identity-verification equipment. We do not run HPLC assays or other analytical procedures on vendor samples ourselves. When TriedRx articles reference lab results, those results come from third-party laboratory reports — either published by vendors as part of their own quality-assurance practice, or published by independent researchers who tested samples and made their data public.

TriedRx is not a retailer, pharmacy, or compounder. We do not sell, dispense, prescribe, ship, or administer any peptide or therapeutic.

TriedRx is not a medical service. We do not provide individual medical advice, diagnose conditions, or establish patient-provider relationships.

Independence from Vendors

TriedRx does not accept advertising, affiliate commissions, sponsored posts, or paid placement from peptide vendors, compounding pharmacies, research-chemical suppliers, clinics, telehealth services, supplement brands, or any commercial entity whose products we review or rank.

We do not let vendors preview rankings drafts prior to publication. We reject vendor-submitted data when we cannot independently verify it against a documented third-party source. Vendor-offered free samples, promotional arrangements, and exclusivity deals are declined as a matter of editorial policy.

Our operating costs are covered by readers through a reader-supported membership (planned) and by the founders' personal investment during the site's launch phase. If this ever changes, the updated funding model will be disclosed prominently on this page and on the homepage.

Source Hierarchy

Every substantive claim on TriedRx is drawn from one of the following, in order of preference:

Peer-reviewed primary research — original studies published in indexed journals, identified by DOI or PMID.
Clinical trial registries — including ClinicalTrials.gov (NCT IDs), EU CTR, WHO ICTRP, and analogous registries.
Regulatory filings and reference materials — FDA prescribing information, EMA assessment reports, Health Canada product monographs, and comparable sources.
Systematic reviews and meta-analyses from recognized methodological groups (Cochrane, etc.).
Third-party lab reports for sample purity and identity data — certificates of analysis and chromatography reports that vendors publish as part of their quality-assurance practice, or that independent researchers have tested and made public. TriedRx does not run these assays in-house. We archive, date, and link the third-party sources we cite.

We do not cite: vendor product pages, vendor-hosted blog posts, community forums, social media posts, or AI-generated summaries as primary evidence. Community-reported dosing ranges may appear on TriedRx only when explicitly labeled as "self-report community data" and accompanied by a caveat explaining the absence of controlled methodology.

What We Will Publish

Peptide research profiles summarizing mechanism, pharmacokinetics, and the clinical/preclinical literature.
Vendor rankings based on a transparent rubric that aggregates third-party lab reports, transparency disclosures, reputation signals, regulatory actions, and operational data.
Dosing protocol references drawn from published studies, with explicit labeling of study context and limitations.
Reconstitution, storage, and administration reference material presented as educational summaries of published practice.
Methodology disclosures, including which data sources we use, how they are weighted in the vendor rubric, and what kinds of data we do not have access to.

What We Will Not Publish

Dosing recommendations framed as individual medical advice.
Claims of therapeutic efficacy for peptides that lack the relevant regulatory approval.
Before/after imagery, case studies, or anecdotes framed as representative outcomes.
Commercial discount codes, affiliate links, or "where to buy" callouts on educational pages.
Content positioning any peptide as a treatment, cure, or prevention for a named disease, unless that indication is supported by FDA approval or equivalent.
Content that targets minors, pregnant individuals, or other populations for whom peptide research data are inadequate.

Review and Verification Process

Every article goes through the following pipeline before publication:

Research draft. An assigned writer gathers primary sources and drafts the article against the TriedRx structural template.
Citation check. A second reviewer verifies that every factual claim maps to a cited source and that each cited source says what the article claims it says.
Numerical verification. Reconstitution math, unit conversions, and dose calculations are re-derived independently by a second reviewer.
Vendor-data verification. For articles referencing vendor rankings, a reviewer confirms the underlying third-party lab reports and transparency disclosures are current, sourced, and archived.
Legal review. The reviewer confirms the article carries required disclaimers, avoids therapeutic claims for non-approved indications, and does not inadvertently provide individual medical guidance.
Publication and dating. Articles carry a visible "Last updated" date. When substantive changes are made, the update history is preserved in the article metadata.

Corrections and Updates

We correct errors promptly and visibly. When a correction materially changes a claim, dose range, citation, or conclusion, we note the correction at the top of the affected article and preserve the correction history. Reader-submitted corrections are welcomed via our contact page and are reviewed within five business days.

If new primary literature meaningfully changes a protocol range or mechanism statement we have previously published, we update the affected articles and flag the change in our changelog.

Conflicts of Interest

Contributors disclose any relationships — financial, professional, or personal — with peptide vendors, compounding pharmacies, clinics, or supplement brands. Contributors with material conflicts are recused from reviewing content where that conflict is relevant. A current disclosure register is maintained internally and is available to readers on request.

Writing Style

TriedRx writes in the third person, editorial voice. We do not address the reader as if they were a patient. We describe what studies report rather than prescribing what any individual should do. We prefer precise language ("Reported protocols in the preclinical literature cluster around…") over promotional language ("the best dose is…").

We do not use AI-generated prose as finished content. Language models may assist research, summarization, and drafting support, but all published text is reviewed, edited, and attested by human editors who carry the standards described above.

Reader Expectations

TriedRx is written for readers 18 and over who are researching peptides for educational purposes. We expect readers to consult licensed healthcare professionals before making decisions about their personal health, to comply with applicable laws in their jurisdictions, and to understand that scientific knowledge about peptides evolves — what is accurate today may require revision as new studies are published.

If any of the above is inconsistent with what you expect from a peptide information site, TriedRx may not be the right source for you. We would rather lose a reader than compromise these standards.

---

Questions, corrections, or conflict-of-interest disclosures: please use the Contact page to reach the TriedRx editorial team.

Related policies: Medical Disclaimer · Research Use Disclaimer

Last updated: April 20, 2026